SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Holly Shill, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  2. 2
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  3. 3
    Christian Villavicencio, Alba Ramírez-Sarmiento, Ángel Gayete, Santiago Grau, Mauricio Orozco-Levi, Early Pleuropulmonary Toxicity Associated With Cabergoline, an Antiparkinsonian Drug, Archivos de Bronconeumología ((English Edition)), 2007, 43, 9, 519

    CrossRef

  4. 4
    Christian Villavicencio, Alba Ramírez-Sarmiento, Ángel Gayete, Santiago Grau, Mauricio Orozco-Levi, Toxicidad pleuropulmonar precoz asociada al tratamiento con cabergolina, un fármaco antiparkinsoniano, Archivos de Bronconeumología, 2007, 43, 9, 519

    CrossRef

  5. 5
    Katherine Grosset, Fiona Needleman, Graeme Macphee, Donald Grosset, Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five-drug dose conversion table, Movement Disorders, 2004, 19, 11
  6. 6
    Ron Tintner, Joseph Jankovic, Dopamine agonists in Parkinson’s disease, Expert Opinion on Investigational Drugs, 2003, 12, 11, 1803

    CrossRef

  7. 7
    Ergun Y. Uc, Andrea J. DeLeo, Robert L. Rodnitzky, Clinical Trials in Neurologic Practice, 2001,

    CrossRef

  8. 8
    Werner Poewe, Gregor K. Wenning, Apomorphine: An underutilized therapy for Parkinson's disease, Movement Disorders, 2000, 15, 5
  9. 9
    A Lledó, Dopamine agonists: the treatment for Parkinson's disease in the XXI century?, Parkinsonism & Related Disorders, 2000, 7, 1, 51

    CrossRef

  10. 10
    Mark Stacy, Pharmacotherapy for Advanced Parkinson's Disease, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2000, 20, 1P2
  11. 11
    Lieng H. Ling, J. Eric Ahlskog, Thomas M. Munger, Andrew H. Limper, Jae K. Oh, Constrictive Pericarditis and Pleuropulmonary Disease Linked to Ergot Dopamine Agonist Therapy (Cabergoline) for Parkinson's Disease, Mayo Clinic Proceedings, 1999, 74, 4, 371

    CrossRef

  12. 12
    Ali Samii, Shallen R. Letwin, Donald B. Calne, Prospects for new drug treatment in idiopathic parkinsonism, Drug Discovery Today, 1998, 3, 3, 131

    CrossRef